Michael G. Kelly, PhD: President & CEO, Director, Co-Founder

Member TACT, Scientific Advisor and Former CSO, CureDuchenne

Former President, Renovis, Inc. (Evotec), multiple R&D positons at Amgen, Wyeth (Pfizer), GSK

John Kincaid: Director, Co-Founder

Former VP and Managing Director, Synterys, Inc.

Former Director, Drug Discovery, Renovis, Inc. (Evotec), multiple R&D positions at Amgen, ImClone Systems (Lilly), Abbott

Mark P. de Souza, PhD: COO, Director, Co-Founder

Executive Chairman, PellePharm; President & CEO, Chromaderm and FIBRX Tissue Repair.

Former Founding President & CEO, Lotus Tissue Repair, (Shire) and VP Business Development, Dyax (Shire)

Giles Campion, MD: Chief Medical Officer 

CMO, Albumedix, Ltd.

Former CMO, Prosensa (Biomarin). Multiple VP positions at GE Healthcare, Novartis, SmithKline Beecham

Chris O’Mara, MS: Sr. Clinical Trial Manager

Former Clinical Trials Specialist, Ultragenyx, Inc.

Former Senior Clinical Research Coordinator, University of California, San Francisco